Previous Article | Next Article ![]()
J Virol, August 1998, p. 6456-6464, Vol. 72, No. 8
Department of Molecular Genetics and
Microbiology, School of Medicine, State University of New York at
Stony Brook, Stony Brook, New York 11794
Received 10 November 1997/Accepted 5 May 1998
Brefeldin A (BFA), an inhibitor of intracellular vesicle-dependent
secretory transport, is a potent inhibitor of poliovirus RNA
replication in infected cells. We have determined that the unknown
mechanism of BFA inhibition of replication is reproduced in the
cell-free poliovirus translation, replication, and encapsidation system. Furthermore, we provide evidence suggesting that the cellular mechanism targeted by BFA, the GTP-dependent synthesis of
secretory transport vesicles, may be involved in viral RNA replication
in the system via a soluble cellular GTP-binding and -hydrolyzing activity. This activity is related to the ARF (ADP-ribosylation factor)
family of GTP-binding proteins. ARFs are required for the formation of
several classes of secretory vesicles, and some family members are
indirectly inactivated by BFA. Peptides that function as competitive
inhibitors of ARF activity in cell-free transport systems also inhibit
poliovirus RNA replication, and this inhibitory effect can be
countered by the addition of exogenous ARF. We suggest that BFA
inhibition of replication is diagnostic of a requirement for ARF
activity in the cell-free system.
0022-538X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Brefeldin A Inhibits Cell-Free, De Novo Synthesis
of Poliovirus

and
*
Corresponding author. Mailing address: Department of
Molecular Genetics and Microbiology, School of Medicine, State
University of New York at Stony Brook, Stony Brook, NY 11794-5222. Phone: (516) 632-8787. Fax: (516) 632-8891. E-mail:
wimmer{at}asterix.bio.sunysb.edu.
Present address: Center for Advanced Biotechnology and Medicine,
Rutgers University, Piscataway, NJ 08854-5638.
Present address: Abbott Laboratories, Abbott Park, IL
60064-3500.
This article has been cited by other articles:
| J. Bacteriol. | Mol. Cell. Biol. | Microbiol. Mol. Biol. Rev. |
|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|